News Focus
News Focus
Followers 94
Posts 5890
Boards Moderated 1
Alias Born 01/09/2014

Re: None

Thursday, 10/23/2014 11:58:16 AM

Thursday, October 23, 2014 11:58:16 AM

Post# of 405212
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin

http://finance.yahoo.com/news/cellceutix-announces-positive-top-line-155109970.html

Something happened - which unleashed the power of our imagination...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y